BridgeBio Pharma (2CL) Technical Analysis
Technical Sentiment
Overall ConsensusStrong Buy
4Bearish
1Neutral
16Bullish
Technical Analysis ConsensusNeutral
4Bearish
1Neutral
4Bullish
Moving Average ConsensusStrong Buy
0Bearish
0Neutral
12Bullish
1 Day timeframe · Data as of Oct 30, 2026
- BridgeBio Pharma’s (2CL) Moving Averages Convergence Divergence (MACD) indicator is 0.86, suggesting BridgeBio Pharma is a Sell.
- BridgeBio Pharma’s (2CL) 20-Day exponential moving average is EUR 61.40, while BridgeBio Pharma’s (2CL) share price is EUR 66.66, making it a Buy.
- BridgeBio Pharma’s (2CL) 50-Day exponential moving average is EUR 62.03, while BridgeBio Pharma’s (2CL) share price is EUR 66.66, making it a Buy.
BridgeBio Pharma (2CL) Pivot Points
1 Day timeframe · Data as of Oct 30, 2026
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 63.14 | 63.39 | 63.89 | 64.14 | 64.64 | 64.89 | 65.39 |
| Fibonacci | 63.39 | 63.68 | 63.85 | 64.14 | 64.43 | 64.60 | 64.89 |
BridgeBio Pharma (2CL) Moving Averages
1 Day timeframe · Data as of Oct 30, 2026
| Period | Simple | Exponential |
|---|---|---|
| MA5 | 63.40Buy | 63.97Buy |
| MA10 | 62.14Buy | 62.53Buy |
| MA20 | 60.41Buy | 61.40Buy |
| MA50 | 61.61Buy | 62.03Buy |
| MA100 | 64.99Buy | 62.93Buy |
| MA200 | 62.62Buy | 62.15Buy |
- BridgeBio Pharma’s (2CL) 10-Day exponential moving average is EUR 62.53, while BridgeBio Pharma’s (2CL) share price is EUR 66.66, making it a Buy.
- BridgeBio Pharma’s (2CL) 100-Day exponential moving average is EUR 62.93, while BridgeBio Pharma’s (2CL) share price is EUR 66.66, making it a Buy.
- BridgeBio Pharma’s (2CL) stock price is EUR 66.66 and BridgeBio Pharma’s (2CL) 50-day simple moving average is EUR 61.61, creating a Buy signal.
- BridgeBio Pharma’s (2CL) stock price is EUR 66.66 and BridgeBio Pharma’s (2CL) 100-day simple moving average is EUR 64.99, creating a Buy signal.
- BridgeBio Pharma’s (2CL) stock price is EUR 66.66 and BridgeBio Pharma’s (2CL) 200-day simple moving average is EUR 62.62, creating a Buy signal.
BridgeBio Pharma (2CL) Technical Indicators
1 Day timeframe · Data as of Oct 30, 2026
| Name | Value | Implied Action |
|---|---|---|
| RSI (14) | 69.74 | Neutral |
| STOCH (9,6) | 100.00 | Sell |
| STOCHRSI (14) | 100.00 | Sell |
| MACD (12,26) | 0.86 | Sell |
| ADX (14) | 18.03 | Buy |
| CCI (14) | 215.62 | Sell |
| ATR (14) | 1.43 | - |
| Ultimate Oscillator | 83.85 | Buy |
| ROC | 12.70 | Buy |
| Bull/Bear Power (13) | 5.07 | Buy |
- BridgeBio Pharma’s (2CL) Relative Strength Index (RSI) is 69.74, creating a Neutral signal.
- BridgeBio Pharma’s (2CL) Trend Strength Indicator (ADX) is 18.03, creating a Buy signal.
- BridgeBio Pharma’s (2CL) Commodity Channel Index (CCI) is 215.62, creating a Sell signal.
- BridgeBio Pharma’s (2CL) Price Rate of Change (ROC) is 12.70, creating a Buy signal.
unique trading strategy with a flexible screenerTry it Now!
FAQ
Is 2CL a Buy, Hold, or Sell?
Based on 2CL’s technical indicators on the 1-day timeframe as of Oct 30, 2026, 2CL is a Strong Buy.
What is 2CL’s RSI (14)?
2CL’s RSI (14) is 69.74, which suggests 2CL is a Neutral.
What is 2CL’s MACD?
2CL’s MACD is 0.86, which suggests 2CL is a Sell.
What is 2CL’s 5-day moving average?
2CL’s 5-day moving average is 63.40, which suggests 2CL is a Buy.
What is 2CL’s 20-day moving average?
2CL 20-day moving average is 60.41, which suggests 2CL is a Buy.
What is 2CL’s 50-day moving average?
2CL’s 50-day moving average is 61.61, which suggests 2CL is a Buy.
What is 2CL’s 200-day moving average?
2CL’s 200-day moving average is 62.62, which suggests 2CL is a Buy.
What is 2CL’s Williams % R (14)?
Currently, no data Available
What is 2CL’s CCI (14)?
2CL’s CCI (14) is 215.62, which suggests 2CL is a Sell.
What is the share price of BridgeBio Pharma?
BridgeBio Pharma's share price is N/A€.
